期刊文献+

高表达MUC1的人食管癌裸鼠移植瘤模型的建立 被引量:1

Establishment of a Human Esophageal Carcinoma Transplantation Model with MUC1 High Expression in Nude Mice
下载PDF
导出
摘要 背景与目的:Mucin-1(MUC1)粘蛋白是一种肿瘤相关抗原,是肿瘤免疫治疗良好的分子靶点之一。本研究建立高表达MUC1的人食管癌裸鼠皮下移植瘤模型,为研究以MUC1为靶点的食管癌的生物治疗提供体内模型。方法:以体外培养的高表达MUC1的人食管癌细胞株EC-109接种于4~5周龄的BALB/c裸小鼠皮下,观察移植瘤生长情况,对移植瘤进行病理组织学检查,采用免疫组化方法检测移植瘤细胞增殖细胞核抗原(proliferating cell nuclearantigens,PCNA),采用流式细胞仪检测移植瘤细胞的细胞周期及MUC1的表达。结果:裸鼠皮下移植瘤成瘤率为86.0%,移植瘤具有与人恶性肿瘤相似的组织学和生物学特点,其平均PCNA标记指数为(63.5±3.6)%、S期细胞百分比(S-phase fraction,SPF)平均值为(37.6±3.7)%、MUC1的平均表达率为97.5%。结论:高表达MUC1的人食管癌裸鼠皮下移植瘤模型具有恶性肿瘤的生物学特性,可用于研究人食管癌的生物学特点,同时为以MUC1为靶点的食管癌的免疫治疗研究提供了良好的体内模型。 BACKGROUND & OBJECTIVE: Mucin-1 (MUC1), a tumorassociated antigen, is an optional molecular target for antitumor immunotherapy protocols. This study was to establish a subcutaneous human esophageal cancer transplantation model with MUC1 high expression in nude mice that closely resembles the biological features of human esophageal cancer, and provide a in vivo model for MUCl-targeting immunotherapy of esophageal cancer. METHODS: Human esophageal carcinoma cell line EC-109 with MUC1 high expression was cultured, and subcutaneously transplanted into BALB/c athymic nude mice (4-5 weeks old). The growth status of transplanted tumor was observed. These subcutaneous tumors were examined histologically. The expression of proliferating cell nuclear antigen (PCNA) was detected by immunohistochemistry. Cell cycle and MUC1 expression of the transplanted tumor cells were analyzed by flow cytometry. RESULTS. Human esophageal carcinoma transplantation models with MUC1 high expression were successfully established in 6 of the 7 nude mice. The histological and biological characteristics of subcutaneous transplanted tumors were similar to those of human esophageal carcinoma. The mean PCNA label index of subcutaneous transplanted tumor cells was (63.5 ± 3.6)%. The mean S-phase fraction of cell cycle was (37.6±3.7)%. The positive rate of MUC1 in subcutaneous transplanted tumor cells was 97.5%. CONCLUSION: Human esophageal carcinoma transplantation model with MUC1 high expression in nude mice is similar to human malignant tumors in biological characteristics, and can be used to investigate the biological characteristics of esophageal carcinoma, as well as provides an applicable animal model for research on MUCl-targeting immunotherapy of esophageal cancer.
出处 《癌症》 SCIE CAS CSCD 北大核心 2007年第7期693-697,共5页 Chinese Journal of Cancer
基金 广州市科技攻关引导项目(No.2004Z3-E0311)~~
关键词 食管肿瘤 裸鼠 移植瘤模型 MUC1 Esophageal neoplasm Nude mouse Transplantation model of carcinoma MUC1
  • 相关文献

参考文献12

  • 1Greenlee R T,Murray T,Bolden S,et al.Cancer statistics,2000[J].CA Cancer J Clin,2000,50(1):7-33.
  • 2何冬梅,张洹.Bcl-2反义寡核苷酸对人肺癌裸鼠移植瘤的抑制作用[J].癌症,2006,25(1):40-44. 被引量:7
  • 3Hanna N,Davis T W,Fidler I J,et al.Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models for experimental metastasis[J].Int J Cancer,1982,30(3):371-376.
  • 4Barreto C B,Azeredo R B,Fucs R,et al.Extrathymic T cells expand in nude mice following different allogeneic stimuli[J].Immunobiology,2003,207(5):339-349.
  • 5Maga G,Hubscher U.Proliferating cell nuclear antigen (PCNA):a dancer with many partners[J].J Cell Sci,2003,116(Pt 15):3051-3060.
  • 6Danbara N,Yuri T,Tsujita-Kyutoku M,et al.Enterolactone induces apoptosis and inhibits growth of colo 201 human colon cancer cells both in vitro and in vivo[J].Anticancer Res,2005,25(3B):2269-2276.
  • 7Remvikos Y,Mosseri V,Zajdela A,et al.Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy[J].Ann N Y AcadSci,1993,698(1):193-203.
  • 8Mukherjee P,Madsen C S,Ginardi A R,et al.Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer[J].J Immunother,2003,26(1):47-62.
  • 9Soares M M,Mehta V,Finn O J.Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection[J].J Immunol,2001,166(11):6555-6563.
  • 10Scholl S M,Balloul J M,Le Goc G,et al.Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer[J].J Immunother,2000,23(5):570-580.

二级参考文献10

  • 1ZIEGLER A, LUEDKE G H, FABBRO D, et al. Induction of apoptosis in small-cell lung cancer ceils by an antisense oligonucleotide targeting the Bcl-2 coding sequence [J]. J Natl Cancer Inst, 1997,89(14) : 1027-1036.
  • 2BLOEM A, LOCKHORST H. Bel-2 antisense therapy in multiple myeloma [J]. Pathol Biol, 1999,47(2):216-220.
  • 3BUCK A C, SHEN C, SCHIRRMEISTER H, et al. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis [J].Cancer Biother Radiopharm, 2002, 17 ( 3 ) : 281-289.
  • 4KLASA R J, BALLY M B, NG R, et al. Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide [ J ]. Clin Cancer Res, 2000,6 (6) : 2492-2500.
  • 5SMITH M R, XIE T, ZHOU Z Z, et al. Efficacy of treatment with antisense oligonucleotides complementary to immunoglobulin sequences of bcl-2/immunoglobulin fusion transcript in a t( 14; 18) human lymphoma-scid mouse model[J]. Clin Cancer Res, 2001,7(2) :400-406.
  • 6VAN DE DONK N W, KAMPHUIS M M, VAN DIJK M, et al. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein [J].Leukemia, 2003,17 ( 1 ) : 211-219.
  • 7MARCUCCI G, BYRD J C, DAI G, et al. Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia [J]. Blood, 2003,101 (2):425-432.
  • 8WATERS J S, WEBB A, CUNNINGHAM D, et al. Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma [J]. J Clin Oncol, 2000, 18(9):1812-1823.
  • 9雷小勇,张洹,何冬梅.Bcl-2反义核酸的设计及对K562细胞凋亡的研究[J].临床血液学杂志,2002,15(6):248-250. 被引量:5
  • 10雷小勇,张洹,何冬梅.Bcl-2反义寡核苷酸增强阿糖胞苷诱导原代白血病细胞凋亡的研究[J].癌症,2002,21(12):1301-1304. 被引量:10

共引文献6

同被引文献8

  • 1龙贤辉,徐勤枝,贺性鹏,隋建丽,安静,白贝,周平坤.5cGy γ射线照射正常人淋巴母细胞基因表达转录谱的变化[J].辐射防护,2006,26(2):78-84. 被引量:9
  • 2王会平,龙贤辉,徐勤枝,白贝,隋建丽,周平坤.基因芯片技术分析20 cGy γ射线照射人淋巴母细胞中差异表达的基因谱[J].辐射防护,2006,26(3):151-156. 被引量:7
  • 3Williams M, Lyu M, Yang YL,et al. IERS, a novel member of the slow-kinetics immediate-early genes. Genomics, 1999, 55 (3) : 327- 334.
  • 4Tachiiri S, Katagiri T, Tsunoda T, et al. Analysis of gene- expression profiles after gamma irradiation of normal human fibroblast. Int J Radiat Oncol Biol Phys, 2006,64( 1 ) :272-279.
  • 5Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res, 2000,885 : 303-321.
  • 6Kis E, Szatmari T, Keszei M, et al. Microarray analysis of radiation response genes in primary human fibroblasts.Int J Radiat Oncol Biol Phys, 2006, 66(5) : 1506-1514.
  • 7Okada A, Kushima K, Aoki Y, et al. Identification of early-responsive genes correlated to valpreic acid-induced neural tube defects in mice. Birth Defects Res A Clin Mol Teratol,2005,73(4):229-238.
  • 8Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitity to radiotherapy, Int J Oncol Biol Phy,2004, 59(4) :928-942.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部